Search
Search Results
##search.searchResults.foundPlural##
-
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1059PDF: 1048HTML: 96 -
Skin Involvement in Primary Systemic Amyloidosis
1624PDF: 888HTML: 4364Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 178Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 151Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 173 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1966PDF: 748HTML: 694 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1201PDF: 507HTML: 221 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1746PDF: 1284HTML: 11492Figure1: 171Figure 2: 174 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2259PDF: 838HTML: 2137New table Chinese children with APL: 160 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2134PDF: 1322HTML: 3501 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1716PDF: 837HTML: 146 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2408PDF: 1590HTML: 626 -
Simultaneous dual pathology in lymph node
1650PDF: 692HTML: 7692Simultaneous dual pathology in lymph node: 173Simultaneous dual pathology in lymph node: 171Simultaneous dual pathology in lymph node: 149Simultaneous dual pathology in lymph node: 188Simultaneous dual pathology in lymph node: 173 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2179PDF: 2007HTML: 173 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2141PDF: 829HTML: 926Patient’s family tree: 168 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2838PDF: 847HTML: 6519Untitled: 226Untitled: 189Untitled: 205Untitled: 210 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3884PDF: 755HTML: 1849 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2608PDF: 831HTML: 14950Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 307 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2498PDF: 1162HTML: 11799 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1698PDF: 696HTML: 3795 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1193PDF: 1065HTML: 201 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2325PDF: 975HTML: 72 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2168PDF: 921HTML: 1636 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1180PDF: 726Html: 96 -
PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace
1979PDF: 823HTML: 279 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1460PDF: 761Suppl. Files: 323Html: 136 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2184PDF: 1168HTML: 2588Study of serum haptoglobin level in thalassemia: 343Figures: 176 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1575PDF: 1207HTML: 189







